WeVote

Bill

Bill

A 8217

Relates to procedures relating to driving while ability impaired by drugs

2025 Regular Session Introduced by Bill Magnarelli

A 8217 changes procedures for drug-impaired driving cases, affecting how testing, evidence handling, and timelines are managed by police and courts.

REFERRED TO TRANSPORTATION
0
WeVote Research Nonpartisan
Bill Summary · A 8217

Summary: Assembly Bill A 8217

Overview

Assembly Bill A 8217, titled "Relates to procedures relating to driving while ability impaired by drugs," is an Assembly bill introduced on May 5, 2025. The bill’s status is currently listed as REFERRED TO TRANSPORTATION. The sponsor listed is William Magnarelli (primary). Related Senate bills include S 2214 (companion) and S 9923 (prior-session).

Purpose and Scope

  • The title indicates the bill would address procedures connected to drug-impaired driving (driving while ability impaired by drugs). The specific procedural changes, requirements, or reforms are not provided in the available summary.
  • As introduced, the bill appears to aim at modifying how cases involving drug impairment are processed within the enforcement and judicial system, potentially affecting arrest procedures, testing, evidence handling, or related administrative steps. The exact scope and language will be defined in the bill text.

Status, Timeline, and Actions

  • Introduced: May 5, 2025.
  • Legislative Actions: Two identical entries show the bill was referred to the Transportation Committee on May 5, 2025. There is no public record here of further actions beyond referral.
  • Next steps typically include committee hearings, potential amendments, floor debate, and eventual votes in the Assembly. If passed, the bill would move to the Senate (or the companion Senate version) for consideration.

Sponsor and Related Legislation

  • Primary Sponsor: William Magnarelli.
  • Related Bills:
    • S 2214 (companion) — listed as a related Senate version.
    • S 9923 (prior-session) — indicates a prior-session related measure.
  • The presence of companion bills suggests alignment between the Assembly and Senate on this policy area, though specific provisions may differ between versions.

Potential Impact and Affected Parties

  • Affected groups likely include drivers suspected of drug impairment, law enforcement agencies, prosecutors, defense attorneys, and courts handling drug-impaired driving cases.
  • Possible impacts (to be confirmed by the bill text) could involve changes to:
    • How drug impairment is detected and documented (testing procedures, admissibility of results).
    • Training or certification requirements for officers and toxicology personnel.
    • Timelines for administering tests or obtaining evidence.
    • Standards for evidence collection, chain of custody, or administrative procedures following a suspected impairment.

Notes

  • The exact substantive provisions, qualifying definitions, penalties, or procedural changes remain unknown until the bill text is released. The summary herein reflects only the information publicly available: introduction date, status, sponsor, and related bills.

Next Steps for Readers

  • Monitor for the release of the bill text and subsequent committee hearings.
  • Compare Assembly A 8217 with its companion S 2214 to understand converging or diverging provisions.
  • Watch for amendments or updates to the procedural framework surrounding drug-impaired driving enforcement.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.